CNS & Neurological Disorders - Drug Targets
Title: Editorial [ Hot Topic:Magic Bullets and Arrows: Biologic Approaches to Treat Substance Use Disorders (Guest Editor: Phil Skolnick and Nora D. Volkow)]
Volume: 10 Issue: 8
Author(s): Phil Skolnick and Nora D. Volkow
Affiliation:
Export Options
About this article
Cite this article as:
Skolnick Phil and D. Volkow Nora, Editorial [ Hot Topic:Magic Bullets and Arrows: Biologic Approaches to Treat Substance Use Disorders (Guest Editor: Phil Skolnick and Nora D. Volkow)], CNS & Neurological Disorders - Drug Targets 2011; 10 (8) . https://dx.doi.org/10.2174/187152711799219299
DOI https://dx.doi.org/10.2174/187152711799219299 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
De Novo Malignancies After Organ Transplantation: Focus on Viral Infections
Current Molecular Medicine The Tangled Mitochondrial Metabolism in Cancer: An Innovative Pharmacological Approach
Current Medicinal Chemistry Memory Improvement with Docosahexaenoic Acid Study (MIDAS)-Brief Review
Current Alzheimer Research The New Era of Nutraceuticals: Beneficial Effects of Polyphenols in Various Experimental and Clinical Settings
Current Pharmaceutical Design Understanding the Basis for the Association of apoE4 with Alzheimers Disease: Opening the Door for Therapeutic Approaches
Current Alzheimer Research Nitric Oxide (NO) Signaling as a Potential Therapeutic Modality Against Psychostimulants
Current Pharmaceutical Design Diet and Neurocognition in Mood Disorders - An Overview of the Overlooked
Current Pharmaceutical Design Predicting Dopamine Receptors Binding Affinity of N-[4-(4-Arylpiperazin- 1-yl) butyl]Aryl Carboxamides: Computational Approach Using Topological Descriptors
Current Drug Discovery Technologies 5-HT<sub>3</sub> Receptor Antagonism: A Potential Therapeutic Approach for the Treatment of Depression and other Disorders
Current Neuropharmacology Safeguarding Childrens Rights in Psychopharmacological Research: Ethical and Legal Issues
Current Pharmaceutical Design Dual Receptor-Specific Peptides Modified Liposomes as VEGF siRNA Vector for Tumor-Targeting Therapy
Current Gene Therapy Editorial (Thematic Issue: Perspectives and Challenges in Rational Exploitation of Phytochemicals in Cure, Control and Management of Diseases)
Current Pharmaceutical Design Dangerous Liaisons: Tau Interaction with Muscarinic Receptors
Current Alzheimer Research Targeting the Fatty Acid Transport Proteins (FATP) to Understand the Mechanisms Linking Fatty Acid Transport to Metabolism
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Urokinase Receptor Interactome
Current Pharmaceutical Design Aryl Maleimides as Apoptosis Inducers on L5178-Y Murine Leukemia Cells (in silico, in vitro and ex vivo Study)
Anti-Cancer Agents in Medicinal Chemistry Selective Hydrogenation of Aromatic Chloronitro Compounds
Current Organic Chemistry Gender Differences in Cerebral Processing of Audio-Visual Information
Neuroscience and Biomedical Engineering (Discontinued) Inflammation and Mood Disorders: Proinflammatory Cytokines and the Pathogenesis of Depression
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Disruption of the Keap1-Containing Ubiquitination Complex as an Antioxidant Therapy
Current Topics in Medicinal Chemistry